和元生物(688238.SH)发预亏，预计2025年归母净亏损1.95亿元-2.37亿元

Core Viewpoint - The company expects to report a net loss attributable to shareholders for the year 2025, with projections ranging from -237 million to -195 million yuan, indicating a reduction in losses compared to the previous year [1] Financial Performance - The anticipated net loss represents a decrease in losses by 84.81 million to 126.81 million yuan compared to the same period last year [1] - The reduction in loss percentage is estimated to be between 26.35% and 39.41% [1]